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Abstract
Background: Medicinal plants have been used traditionally since centuries for wound care and treatment of skin
diseases both in human and animals. Skin diseases are one of the most common reasons for owners to take their
dog to the veterinarian. The demands for treatment and prophylaxis of these diseases are broad. A wide range of
bacteria including antibiotic-resistant bacteria can be involved, making the treatment challenging and bear an
anthropo-zoonotic potential. The aim of this review is to systematically evaluate based on recent scientific literature,
the potential of four medicinal plants to enrich the therapeutic options in pyoderma, canine atopic dermatitis, otitis
externa, wounds and dermatophytosis in dogs.
Results: Based on four books and a survey among veterinarians specialized in phytotherapy, four medicinal plants
were chosen as the subject of this systematic review: Calendula officinalis L. (Marigold), Hypericum perforatum L. agg.
(St. John’s Wort), Matricaria chamomilla L. (syn. Matricaria recutita L., Chamomile) and Salvia officinalis L. (Sage).
According to the PRISMA statement through literature research on two online databases a total of 8295
publications was screened and narrowed down to a final 138 publications for which full-text documents were
analyzed for its content resulting in a total of 145 references (21 clinical, 24 in vivo and 100 in vitro references).
Conclusions: All four plants were proven to have antibacterial and antifungal effects of a rather broad spectrum
including antibiotic-resistant bacteria. This makes them an interesting new option for the treatment of pyoderma,
otitis externa, infected wounds and dermatophytosis. Marigold, St. John’s Wort and Chamomile showed wound-
healing properties and are thus promising candidates in line to fill the therapeutic gap in canine wound-healing
agents. St. John’s Wort and Chamomile also showed anti-inflammatory and other beneficial effects on healthy skin.
Due to the wide range of beneficial effects of these medicinal plants, they should be taken into account for the
treatment of dermatologic diseases in dogs at least in future clinical research.
Keywords: Dog, Dermatology, Calendula officinalis L., Hypericum perforatum L., Matricaria chamomilla L., Salvia
officinalis L., Topical treatment
Background
Skin diseases are one of the most common reasons for
owners to take their dog to the veterinarian [1, 2].
Canine skin diseases include bacterial skin infections,
hypersensitivity disorders, canine atopic dermatitis (CAD),
food adverse reactions, otitis externa, wounds, dermato-
phytosis, neoplasia and parasitic infestations [2, 3]; a range
of diseases with various etiologies and symptoms and thus
diverse demands for treatment. An overview of these dis-
eases with their possibly involved pathogens, pathogenesis
and pathophysiology and demands for therapy and
prophylaxis is presented in Table 1.
Primary and secondary bacterial skin- and ear infections
frequently occur in dogs. Staphylococcus pseudintermedius
is the most common pathogen isolated from primary
pyodermas as well as secondary skin and ear infections in
dogs suffering from CAD or food allergies [4, 5] and car-
riage of methicillin-resistant S. pseudintermedius (MRSP)
appears to be a risk factor for surgical site infections
in dogs [6]. In addition, the opportunistic pathogen
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Pseudomonas aeruginosa is frequently isolated from
ear infections and pyodermas in dogs as well [7].
Thus topical and oral antibiotics are frequently used in
canine bacterial skin, ear and wound infections and the
occurrence of resistance is a major concern. An increasing
antimicrobial resistance in bacteria of the Staphylococcus
intermedius group, isolated from clinical samples from
dogs and cats has been reported [8]. Similar observations
were reported for P.aeruginosa [7].
Treatment of infections associated with antimicrobial
resistant bacteria can be very challenging. Moreover, the
close contact between animals and their owners provides
opportunities for microbial exchange, including MRSP
or multi-drug resistant (MDR) pathogens [9]. It is there-
fore crucial to reduce the use of antibiotics and prevent
further emergence of antimicrobial resistance and develop
new antimicrobial therapies or develop measures that pre-
vent microbial overgrowth. Microbial overgrowth is often
associated with impaired epidermal barrier function such
as seen in CAD. Therefore treatments that combine
antimicrobial effects and anti-inflammatory or epidermal
barrier enhancing effects would be even more desirable.
An additional emerging problem is the reported tole-
rance to the frequently used biocide chlorhexidine gluco-
nate (CHG) solution which has been observed for some
Gram-negative bacteria. Although mostly still effective
against Gram-positive bacteria a recently confirmed link
between antibiotic resistance and use of CHG demands
for stewardship on the use of important biocides and thus
there is a need for alternatives to the current biocides.
Another field affected by bacterial infections is wound
care. The range of bacteria that can be found in infected
wounds, especially bite wounds, is broad [10]. This
makes exploring new treatment options like plant ex-
tracts interesting, even more so as medicinal plants con-
sist of a mix of several compounds that may act against
a broad spectrum of bacteria. However, not only infected
wounds originating from injuries could profit from plant
based antimicrobial agents but also certain surgical site
infections. The latter can be associated with antimicro-
bial susceptible organisms but also MRSP or MDR path-
ogens [6, 11]. Also in the field of wound care there is a
demand for new effective treatment options. Geriatrics
and gerontology are of increasing importance in small
animal care and even though the dogma that cutaneous
wound healing is impaired as a function of age is not
proven in dogs, structural and functional changes in the
skin have been reported [12, 13].
Patients with impaired wound healing could benefit
from substances supporting the healing process. Simi-
larly, patients suffering from CAD could benefit from
treatments which do not only fight bacterial and or yeast
overgrowth/ infections but which also strengthen the
skin barrier. While there are disinfectants and antibiotics
registered for wound care, there are no registered veterin-
ary drugs e.g. on the Swiss market (www.clinipharm.ch)
which aid wound-healing itself.
Dermatophytosis in dogs occurs less frequently but is
important because of its zoonotic potential [3]. Although
current treatments are generally effective [3], additional
treatment [14] options could be beneficial.
As numerous plant species have been used tradition-
ally in Switzerland and other European countries for the
treatment of various skin diseases including wounds
[15–17], it might be an interesting option to look for
alternative treatments in plant extracts. The goal of this
review is thus to systematically evaluate the potential of
four medicinal plants to enrich the therapeutic options
in five relevant fields of canine dermatology: pyoderma,
CAD, otitis externa, wounds and dermatophytosis.
Methods
The methods of this systematic review are in accordance
with the design of study by Ayrle et al. [18] and are
based on the recommendations of the PRISMA state-
ment [19, 20] and the AMSTAR measurement tool [21].
The PICOS scheme [19] was used to design the research
question: the population are dogs, the intervention is a
topical treatment with medicinal plants, the comparator
is no treatment, a placebo or standard treatment, the
outcome is the effect of the plant, the study design
includes in vitro, ex vivo, in vivo or clinical trials. A
detailed description of the systematic review is given in
the Additional file 1.
Selection of plant species
Four recent books on veterinary phytotherapy [15, 22–25]
were manually screened by one person. Each plant men-
tioned as a remedy for dermatologic problems of any kind
was listed and for each plant the number of books in
which it was listed as such was counted. In order to also
include the expertise and experience of specialists in the
selection of plant species, a non-representative survey was
conducted on veterinarians specialized in phytotherapy
attending a conference in 2016. The 30 participants were
given five minutes of time and were asked to spon-
taneously write down a maximum of ten plants they used
most frequently as phytotherapeutic agents for dogs. They
were also asked to give indications for their use. The
received answers were filled into a table where each plant
mentioned was listed together with the field of indication
according to the ATCvet code [26]. A table describing the
results of the screening of the books and the survey is
accessible in Additional file 2.
The plants which were listed as therapeutic agent in
dermatology in all four books or which were mentioned
as such in three books and which were listed according
to the ATCvet code D at least once in the survey, were
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included. The plants mentioned as dermatologically
relevant therapeutic agents in all four books were
Matricaria chamomilla L. (Chamomile) and Calendula
officinalis L. (Marigold). Chamomile also has been
mentioned by three contestants of the survey according
to the ACTvet code D, and Marigold was mentioned four
times. Salvia officinalis L. (Sage) was listed in three books
and it was also mentioned according to the ATCvet code
D three times in the survey. Hypericum perforatum L. agg.
(St. John’s Wort) was listed in three books and was men-
tioned as a skin remedy by one contestant of the survey.
Selection of scientific references
Literature search
For each of the previously selected plants an online bib-
liographic literature search was conducted. An introduc-
tion in scientific literature research was provided by a
professional librarian. The databases used were PubMed
[27] and Web of Science [28]. The literature search
using these databases was conducted between 2017 and
05-03 and 2017-05-11 by one person. The search was
limited on peer-reviewed publications published between
1997-01-01 and 2017-04-30. The search terms for the
keyword search in both databases consisted of the Latin
name of the plant, the English trivial names and the
pharmaceutical denomination in Latin (e.g. Salvia offici-
nalis OR Sage OR salviae officinalis folium). In the
PubMed keyword search, the results were refined with the
subjects “complementary medicine”, “systematic review”,
“toxicology” and “veterinary science”. In the Web of Science
keyword search the results were refined with the research
areas “pharmacology pharmacy”, “integrative complemen-
tary medicine”, “toxicology”, “mycology”, “dermatology”,
“veterinary sciences”, “infectious diseases”, “microbiology”,
“virology”. In PubMed an additional MeSh-Term search
was performed with the MeSh-Term of each plant
(Latin name) and the subheadings “adverse effects”,
“drug effects”, “microbiology”, “pharmacology”, “thera-
peutic use” and “toxicity”.
The use of plant extracts as anti-parasitic agents
and in cancer therapy was not investigated as this
would have exceeded the extent and the purpose of
this review.
Keyword search within EndNote
For each plant species, a term-list search was conducted.
Only references containing the word truncations “anti”,
“astring”, “bioactiv”, “canin”, “constitu”, “derma”, “dog”,
“eff”, “immune”, “pharma” or “wound” in their title or
abstract were included. References containing “intest”,
“gastro”, “pulmo”, “broncho”, “tumor” or “cancer” in
their title or abstract were excluded.
Manual sorting of references according to in- and exclusion
criteria
In order to further determine which publications were
to be included in this review, the titles of the remaining
publications were screened manually by one person and
an in- or exclusion was made according to predefined
in- and exclusion criteria. The references still included
after the manual screening of the titles were screened
and in- or excluded again by reading the abstract and
applying the same criteria as stated above for the
screening of titles.
In- and exclusion criteria
The in- and exclusion criteria were partially self-developed
(based on Table 1) and partially derived from the publica-
tion by Ayrle et al. [18].
Only peer reviewed publications including an abstract
written in English were considered. In order to be
included, publications had to deal with an assessment of
plants in vitro, ex vivo, in vivo or in a clinical trial and/
or the topical use of plants and/or their extracts AND
antimicrobial (antibacterial, antiviral or anti-mycotic)
effects, anti-inflammatory effects, astringent effects,
wound healing, epithelial proliferative or fibroproli-
ferative effects, antipruritic effects, analgesic effects,
other beneficial effects on the skin (e.g., anti-edematous,
protective against water loss etc.), wound treatment, skin
infections (bacterial, mycotic, viral), pruritus, otitis externa,
seborrhea, CAD and other skin conditions occurring in
dogs or being comparable to skin conditions occurring in
dogs or dealing with disinfectant properties.
Publications dealing with ingredients, constituents,
components of plants and detection or extraction of
them were classified as “pharmacognostic publications”,
and these were collected in a separate folder in EndNote
for each plant. Publications referring to adverse effects
or toxic effects of plants were classified as “publications
on unwanted adverse effects” and were also collected in
a separate folder in EndNote for each plant. Publications
reviewing publications were also collected in a folder for
each plant as “review publications”.
Publications without an abstract, which were only
presented on conferences and not in peer-reviewed jour-
nals, investigating a mixture of different plant species in
a combined preparation or dealing with other plant
species than we focused on, were excluded. Also further
publications were excluded: publications dealing with
pathogens other than the main or closely related patho-
gens connected with dermatological disease in dogs (as
shown in Table 1), plants used as food, plant genetics,
cultivation or breeding of plants, plant pathology, plant
protection systems or pesticides, ecology, geology, etho-
logy, sociology, ethnobotany, food technology or food
packaging, the use of the plant as a repellent, insecticide
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or anti-parasitic agent, homeopathic use of the plants
(excluding mother tinctures, which were included), any
anti-inflammatory or analgesic effects of a topically used
plant that is not intended for skin problems (e.g. cream
preparations for topical arthritis or migraine treatment),
the effects of the plants and their extracts on endothelial
cells, anti-inflammatory effects and effects on inflamma-
tory cells but not explicitly connected to their role in the
skin, effects of endophytic fungi and their products
found in/on the plants, antiangiogenic properties if not
connected directly to the skin or wound healing or the
nutritional or mineral content of the plants.
Classification
Subsequently, the included (left over) publications were
divided into the four groups “pharmacognostic publica-
tions”, “publications on adverse effects”, “review publica-
tions” and “finally included publications” (accessible in
Additional file 3).
For the “finally included publications” the full text was
acquired. One publication was excluded as the full text
was not available.
Prior to filling the information of the “finally included
publications” in a table (Additional file 3), a distinction
between “finally included publication” and “reference”
was made:
Finally included publication: one scientific
publication
Reference: one or several clinical, in vivo or in vitro
trial(s) of one plant species within one finally included
publication (one line in Additional file 3). The
references were classified into either “clinical”, “in vivo”
or “in vitro” references. References investigating skin
diseases occurring naturally in the investigated animal
species (including human) were defined as “clinical
references”. References investigating skin diseases and
the effect of plants in human or animal models were
categorized as “in vivo” references. Studies using
pathogens, cell layers or ex vivo models were
categorized as “in vitro” references. According to this
definition, one finally included publication can
contain several references (e.G. a publication on the
same in vitro trial using several plants, e.G.
Marigold, chamomile and sage, results in three
references and one publication describing an in vitro
and an in vivo trial with one plant species results in
two references.) a publication reporting on several
trials of the same category (clinical, in vivo, in vitro)
results in one reference.
Scoring system
Based on the pre-defined demands for therapy and
prophylaxis as described in Table 1, several possible
effects of the plants and their extracts were added to the
table (Additional file 3) as rows. If a reference showed
one of these effects to be proven in a statistically signifi-
cant way, it was marked as a “proven reference” and as a
“+” in the table. If the reference was not able to show
that an effect was proven or if the results were not
statistically significant, it was marked as a “disproven
reference” and as a “0” in the table. Uncertain effects
presented in references (e.g. if the effect was not seen
consistently) or if the reference did not state a clear re-
sult concerning that effect, these references were marked
as an “uncertain reference” and a “?” in the table. If a
reference showed the opposite of an effect (e.g. anti-an-
giogenic instead of pro-angiogenic) it would be marked
as an “opposite reference” and a “-” in the table.
Ultimately, for each plant and each effect, the amounts
of proven, disproven, uncertain and opposite references
were counted and the results were presented.
Results
Of the 8295 publications retrieved from databases, a
final total of 138 publications were selected to be filled
in the table, accessible in ‘Additional file 3’, resulting in a
total of 145 references. The selection process of publi-
cations to be included into this table is described in Fig. 1
and a more detailed description of the number of publi-
cations found and included after different steps is
provided in Table 2.
Figure 2 illustrates the distribution of the publication
dates for each plant species over the 20 years included in
this review in two-year-steps. For all plant species an
increasing number of publications could be found for
the last decade compared to the time period between
1997 and 2007.
For each plant, the amount of total references result-
ing from the included publications and their distribution
into clinical, in vivo and in vitro references is presented
in Fig. 3. Most publications were included for St. John’s
Wort and the most references resulted for this plant.
Marigold was the plant with the least publications and
references, but had the greatest percentage of in vivo
and clinical trials. The highest percentage of in vitro
references was found for Sage. Table 3 presents the
number of in vitro and clinical/in vivo references which
confirm (“+”), do not give a clear result for (“?”), do not
confirm (“0”), or which show the opposite of (“-”) each
of the total 16 effects required for the treatment of ca-
nine skin diseases. Overall, references showed seven
times the opposite of the required effects while 198
times references were able to prove the required effect.
Topical antibacterial, anti-fungal, anti-inflammatory and
anti-erythematous effects were described in references of
all four plants investigated. St. John’s Wort and Sage
were the plants with the highest number of references
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investigating antibacterial effects and they were the only
ones for which the activity against biofilms was studied and
confirmed. Synergistic activities of plant extracts with anti-
biotics or disinfectants were only investigated for
Chamomile and Sage. Sage was the only plant for which no
studies related to wound-healing potential were found. For
St. John’s Wort and Chamomile, publications investigating
and showing analgesic effects were found.
In the category “hypothesis proven”, various skin rele-
vant effects were shown (Additional File 3). For Mari-
gold, these effects included an increased expression of
connective tissue growth factor and α-smooth muscle
actin which was shown in an in vitro [29] as well as in
an in vivo study [29], the increased expression of hya-
luronic acid in human dermal fibroblasts and a pro-
tective effect against the induction of irritant contact
dermatitis [30]. For St. John’s Wort, a protective effect
on hair follicles and collagen was shown if applied
directly after thermal burns [31]. Another study proved
an inhibitory effect on hypodermal stasis in burn
wounds indicating a protective effect on the perfusion in
this area, preventing it from further damage through is-
chemia [32]. Two references reported an inhibitory
effect of St. John’s Wort extract and hyperforin on the
allostimulatory capacity of epidermal cells in vivo and in
vitro, thus proving to decrease the epidermal cells’(EC)
Fig. 1 Process of the systematic literature review
Table 2 Overview of the amount of scientific publications collected for each plant species after each step of the review process
Plant name (Latin) Calendula officinalis Hypericum perforatum Matricaria chamomilla Salvia officinalis
Plant name (English) Marigold St. John’s Wort (German) Chamomile Sage
All publications imported from WoSa and PMb
after removal of duplicates
536 2239 937 3319
After keyword search in titles and abstracts with EndNote 403 1728 683 1891
Included after manual screening of titles and abstracts 78 120 90 72
Pharmacognostic studies 36 42 21 34
Reviews 16 18 28 5
Publications on adverse effects 1 12 7 2
Finally included publications 25 48 34 31
Resulting referencesc 29 50 34 32
aWeb of Science [28], bPubMed [27], cReference = one or several clinical, in vivo or in vitro trials of one plant species within one finally included publication (= one
line in dditional file 3)
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Fig. 2 Distribution of the publication dates of all review included publications sub-divided by plant species
Fig. 3 Distribution of the experimental design (in vitro, in vivo, clinical) of all review included references sub-divided by plant species
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Table 3 Summary of the amount of references proving (+), giving an unclear result (?), showing no effect (0) or showing the
opposite effect (−) for each criterion investigated for each plant species
Type of reference Calendula Hypericum Matricaria Salvia
in vitro in vivo +
clinical
in vitro in vivo +
clinical
in vitro in vivo +
clinical
in vitro in vivo +
clinical
Anti-bacterial + 71 192 113 14 205
? 16 17
0 18 39 110
–
Synergism with antibiotics/ disinfectants + 111 412
?
0 113
–
Anti-fungal + 314 1015 516 717
?
0 118 419 320 321
–
Anti-biofilm + 322 223
?
0
–
Anti-pruritic + 124 325
? 126
0
–
Wound-healing + 827 828 529
? 130
0 131
–
Fibro-proliferative + 332 133 134
? 235
0 136 337 238 139
– 240 141
Fibro-migrative + 242 243
?
0 144
– 145
Collagen-enhancing + 146 247 248 449 150
?
0 151
–
Pro-angiogenic + 252 353 354
?
0 355
– 156
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ability to present alloantigens in a mixed EC lymphocyte
reaction and inhibit T cell proliferation [33]. Chamomile
was proven to have a proliferative effect on keratinocytes
in vitro [34] and in one study, the topical application of
Chamomile essential oil lowered the serum IgG1, hista-
mine and IgE level in atopic dermatitis-like mice [35].
It was also proven that Chamomile can increase the
permeability of skin for caffeine and salicylic acid [36]
and has good hair care properties in shampoo
formulations [37]. Sage was shown to reduce axillary mal-
odor levels when used in a deodorant stick [38] and an
in vitro study showed that Sage ethanol extract inhib-
ited NGF-induced neuritic outgrowth in an in vitro
study based on a PC12 cell-line [39].
Discussion
The large number of publications from the last twenty years
shows a sound base of evidence-based knowledge about
Table 3 Summary of the amount of references proving (+), giving an unclear result (?), showing no effect (0) or showing the
opposite effect (−) for each criterion investigated for each plant species (Continued)
Type of reference Calendula Hypericum Matricaria Salvia
in vitro in vivo +
clinical
in vitro in vivo +
clinical
in vitro in vivo +
clinical
in vitro in vivo +
clinical
Anti-inflammatory + 157 258 359 360 161 262
? 163 164
0 265 166
– 167
Anti-erythematous + 168 269 270 271
? 172
0 273
–
Anti-edematous + 374 175 176
?
0 177
–
Analgesic + 278 279
?
0
–
Beneficial for skin + 280 381 182
?
0 183
–
Hypothesis proven + 284 485 586 1087 288 589 390 191
? 192
0 193 194
– 195
Total + 20 22 43 40 19 24 37 6
? 0 1 3 3 0 3 0 0
0 2 0 5 14 10 3 3 0
– 2 0 4 1 0 0 0 0
1[62, 65–70]; 2 [53, 76–78, 138–152]; 3 [66, 68, 93, 97, 98, 100, 153–157]; 4 [158]; 5 [38, 93, 118, 119, 123–126, 157, 159–169]; 6 [170]; 7 [171];8 [172]; 9 [102, 103, 173];
10 [174];; 11 [93]; 12 [93, 117–119]; 13 [167] 14 [65, 69, 175]; 15 [76, 79, 139–141, 151, 177, 178, 176, 179]; 16 [97]; 17 [120–122]; 18 [68]; 19 [78, 138, 152, 170]; 20 [68,
102, 103]; 21 [160, 166, 180]; 22 [79, 149, 150]; 23 [168, 181]; 24 [82]; 25 [35, 37, 104]; 26 [182]; 27 [29, 57–63]; 28 [31, 32, 82, 84, 87, 88, 183, 184]; 29 [104]; 30 [81];31
[185]; 32 [29, 64, 186]; 33 [29]; 34 [183]; 35 [45, 143];36 [187]; 37 [84, 86, 185]; 38 [64, 187]; 39 [105]; 40 [52, 64]; 41 [87]; 42 [29, 64]; 43 [45, 188]; 44 [64]; 45 [52]; 46 [189]; 47
[61, 62]; 48 [45, 188]; 49 [32, 86, 88, 183]; 50 [105]; 51 [185]; 52 [62, 190]; 53 [29, 62, 190]; 54 [86, 88, 183]; 55 [84, 87, 185]; 56 [191]; 57 [62]; 58 [33, 83]; 59 [33, 84, 85]; 60
[35, 104, 109]; 61 [192]; 62 [55, 193]; 63 [61]; 64 [88];65 [86, 87]; 66 [105]; 67 [189]; 68 [71] 69 [81, 194]; 70 [37, 109]; 71 [55, 193]; 72 [182];73 [88, 92]; 74 [32, 81, 82]; 75
[109]; 76 [55]; 77 [88]; 78 [81, 82]; 79 [104, 113]; 80 [71, 72] 81 [84, 86, 87]; 82 [115]; 83 [92] 84 [29, 50]; 85 [29, 30, 60, 195]; 86 [33, 52, 83, 143, 191]; 87 [31, 81, 82, 88, 92,
171, 185, 194]; 88 [34, 36]; 89 [35, 37, 108, 109, 115]; 90 [39, 120, 192]; 91 [38]; 92 [182];93 [196]; 94 [197]; 95 [189]
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these four medicinal plants. Although the number of publi-
cations focusing on skin related topics is smaller, the
amount is still in a promising range. There is a large num-
ber of pharmacognostic publications (a total of 133 for all
four plant species) indicating that a broad knowledge on
the constituents of the investigated plants is available.
The distribution of publication dates of the publications
fitting the topic of this review indicates that there is a
trend in investigating the therapeutic potential of these
four plants in the context of skin diseases. Interestingly,
the amount of publications found on St. John’s Wort (H.
perforatum) is larger than for the other plants. St. John’s
Wort has been receiving quite some attention in the last
few years as many consumers are already using this medi-
cinal plant for various indications such as depression
therapy, urging researchers to investigate on the broad
spectrum of effects of this plant [40].
Evaluation of the search strategy
English or German scientific publications investigating
the topical use of Calendula officinalis, Hypericum
perforatum, Matricaria chamomilla and Salvia officinalis
on dog skin are missing in the last 20 years. Due to this,
the goal of this review was to extrapolate therapeutic
options of the four medicinal plants for the topical use
in dog skin based on studies investigating effects of these
plants in other animals’ (and human) skin, microorga-
nisms involved in canine skin diseases or closely related
to those, cell cultures and other skin in vitro models. In
order to avoid source selection bias, four standard text-
books and a survey among experts were used to choose
the four most promising plants. It is, however, possible
that the chosen books and the use described by the
experts in the survey were influenced by each other
which would result in a certain sampling bias. Using two
different, independent databases and the Mesh Terms
function of PubMed reduced the risk of introducing
database bias. Also, by limiting the included publications
to studies published not before 1997, some important
but older research may have not been included in the
present review. On the other hand, studies published up
to 2017 were included, decreasing this bias.
Varying chemistry of plants
Interpreting the results of studies investigating effects of
plant extracts, it is important to consider that results
may vary depending on the type of extract and the ex-
traction method used [41, 42] and the amount of active
constituents in the plant material. The amount of active
constituents in the plant material itself can be influenced
by several environmental factors [43]. Variation between
the used plant parts and between subspecies of the
plants needs to be considered as well [44, 45]. But the
widely varying concentrations of active constituents in
traditionally home-made plant-based remedies neverthe-
less seems to lead to a high level of satisfaction with the
outcome of their use by Swiss farmers [46]. A problem
is that not all available studies precisely describe the
extracts used and therefore a minimum standard on
how to report on the constituents should be re-
quested for future studies [47]. To extract studies
with comprehensible data and to create comparable
units based e.g. on the concentration of raw material
in the final preparations is possible but would go be-
yond the scope of this review.
Multicomponent composition
The range of pharmacognostic publications found and
considered for this review show that there is a broad
spectrum of components found within one medicinal
plant species, and most of the effects shown cannot be
traced back to only one but multiple components of the
plants and their extracts. For many effects, the groups of
constituents causing them are known. For Chamomile
for example, the components showing anti-bacterial
activity were identified to be coumarins, flavonoids, phen-
olic acids, fatty acids and essential oil components [48].
The component bisabolol - which can also be found in
Marigold [49] - is known to have anti-irritant and anti-in-
flammatory properties [37]. Oleanolic acid extracted from
Marigold has been proven to be active against
Gram-positive and Gram-negative bacteria [50]. A well-
known component of St. John’s Wort is hypericin, a
substance which is responsible for the photo-sensitizing
effects of the plant [51]. Another ingredient found in St.
John’s Wort, hyperforin, has been shown to have
anti-proliferative and anti-migrative effects on fibroblasts
[52] and α-pinene seems to be one of the components
causing the antibacterial activity of St. John’s Wort [53].
Also for Sage, a wide range of components has been
described. The terpene fraction of this medicinal plant
is involved in many of the effects of Sage as it contains
α- and β-thujone, 1,8-cineole, linalool, camphor and a
range of other substances [54]. Ursolic acid from Sage
has been shown to be one of the components responsible
for its anti-inflammatory potential [55].
Calendula officinalis - Marigold
A well-known traditional indication in Switzerland for
the use of Marigold is wound care [15, 56]. This field
of use can be well justified by the results of this re-
view as 8 clinical and in vivo references confirmed
this effect [29, 57–63]. There were no references
showing any result different than Marigold aiding the
healing process. According to the publications
assessed in this review, this effect can mainly be at-
tributed to the fibro-proliferative, pro-angiogenic and
collagen-enhancing effects of Marigold which were
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confirmed in several clinical, in vivo and in vitro ref-
erences and also the fibro-migrative effect shown in
two in vitro references [29, 64].
Seven references investigating the anti-bacterial effects
of Marigold were identified, and all of them confirmed
Marigold to inhibit the growth of skin-relevant bacteria
[62, 65–70]. Even though the anti-bacterial activity of
Marigold was not reported to protect against a broad
spectrum of bacteria, and even though it may not be the
strongest compared to other plant extracts [68], it still
adds to Marigold being an interesting option for the
treatment of wounds as it combines wound-healing and
antibacterial effects.
Three in vitro references also confirmed an antifungal
effect and only one in vitro study did not detect any
anti-fungal activity of Marigold. This might justify the
traditional use of this plant in fungal skin infections [15].
Two references confirmed beneficial effects on the skin
such as an increase in skin moisture content, a decrease
in the trans-epidermal water loss and an increased firm-
ness of the skin [71, 72]. Such properties might also be
interesting for the topical treatment of dogs with CAD
as the barrier function of the skin is impaired in these
diseases. Again, Marigold could possibly be a treatment
fighting secondary infections and strengthening the skin
at the same time.
Marigold has also been used traditionally to treat
skin inflammation [15]. But the references included in
this review show contradictory results and do not
provide very strong evidence for the usefulness of
Marigold in the treatment of canine skin inflamma-
tion [62, 63, 72, 73].
One publication on unwanted adverse effects was
found describing contact sensitization to Marigold in
humans affecting approximately 2% of the patients
tested [74]. There are some other reports describing
this problem to be more or less severe [73, 75] but
none of the 13 in vivo and clinical references in-
cluded in this review reported on any unwanted adverse
effects. Also, one of these references conducted an irritant
assay of a cream containing 1% of Marigold extract, dem-
onstrating absence of skin irritation and a low irritability
index in rabbits’ eyes [60]. Thus, marigold’s safety remains
controversial.
Based on the strong evidence supporting the wound-
healing effect of Marigold, this plant can be considered
beneficial in canine wound care. As there are no veteri-
nary drugs e.g. on the Swiss market which support
wound healing other than just by disinfecting the
wound, Marigold could fill a gap in therapeutic needs by
aiding the healing process. The beneficial effects of
Marigold on the skin could be used as a component of
shampoos or sprays for normal skin care in healthy dogs
as well as for dogs with skin problems.
Hypericum perforatum – St. John’s Wort
St. John’s Wort is a traditionally used remedy for skin al-
terations and sores in livestock [56], making it interest-
ing to further investigations on effects and possible
applications on dog skin.
The most frequently confirmed skin related effect of
St. John’s Wort in this review was the antibacterial activ-
ity: a total of 21 references investigated this and 20 of
them confirmed its antibacterial properties. It inhibited
not only Gram-positive but also Gram-negative bacteria
while generally showing stronger activity against the
Gram-positive bacteria such as S. aureus, S. epidermidis
and E. faecalis. St. John’s Wort was also proven to be
effective against E. coli, P. aeruginosa, Proteus mirabilis,
Proteus vulgaris, S. epidermidis, several Streptococcus
spp., Propionibacterium acnes, several Mycobacterium
spp., and Clostridium histiolyticum.
Three references confirmed the activity of St. John’s
Wort against methicillin-resistant S. aureus (MRSA)
[76–78]. One reference also confirmed activity against
gentamycin-methicillin-resistant S. aureus [76]. Thus, St.
John’s Wort could be a new promising option for treat-
ment of skin infections with Gram-positive bacteria in-
cluding possibly MRSP. Another possible field of use for
St. John’s Wort might be fungal skin infections as out of
a total of 14 references investigating this (all of them in
vitro), 10 did confirm the antifungal activity of the plant.
Six references showed St. John’s Wort to be effective
against dermatophytes including Trichophyton menta-
grophytes, Microsporum gypseum, Microsporum canis
and Trichophyton rubrum. There were no references
investigating the effect of St. John’s Wort on Malassezia
pachydermatis but one reference investigated and
proved its activity against Malassezia furfur [79]. This
shows that St. John’s Wort might inhibit the growth of a
Malassezia species indicating that it might just as well
be active against M. pachydermatis. Another factor in
support of its anti-yeast activity is the fact that in eight
references efficacy against Candida albicans was demon-
strated. However C. albicans is infrequently causing
infections in dogs but rather in humans but in general
Candida spp. are even more resistant to azole antifungal
agents than M. pachydermatis [80]. Therefore, it might
be worthwhile to confirm efficacy of St John’s wort for M.
pachydermatis as well. St. John’s Wort has been proven to
be effective in 8 out of 10 references investigating its
wound healing potential in in- and excisional wounds as
well as experimental thermal burns in rats and in two hu-
man clinical trials using St. John’s Wort for the treatment
of pressure sores and wounds after a cesarean section.
The mechanism of the wound healing activity has not
been identified as the references included in this review
investigating fibroproliferative and fibromigrative effects
as well as collagen-enhancing and pro-angiogenic
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properties reported rather mixed results. Still, the refer-
ences evaluating the wound-healing potential of St. John’s
Wort indicate that it can be helpful for wound care and as
it has a rather broad-spectrum antimicrobial activity, it
would qualify especially well for the treatment of infected
wounds including bite wounds. Additionally, there were
two references investigating and proving topical analgesic
effects of St. John’s Wort [81, 82], which might present an
additional reason to use this plant for wound care.
The results of references considering the anti-in-
flammatory effect of St. John’s Wort do show a tendency
towards beneficial effects: while five references confirmed
an anti-inflammatory effect [33, 83–85], two could not
confirm it [86, 87], and one reference did not show a
clear result [88]. Two references show significant anti-
erythematous and three references edema reducing effects
of St. John’s Wort (Table 3). Future studies need to be
performed in order to investigate St. John’s Wort’s anti-in-
flammatory properties for the treatment of skin disease.
Three references showed further beneficial effects like
an increased tensile strength (measured with a tensio-
meter) of the skin after external St. John’s Worts wound
treatment, an interesting aspect maybe not only for the
treatment of wounds. However, the cellular process
behind this finding remains unclear.
Side effects of the use of St. John’s Wort preparations
have been discussed controversial. Photosensitization
was reported for the topical use of St. John’s Wort in
some studies [51, 89, 90]. On the other hand a recent
safety assessment excerted by the Cosmetic Ingredient
Review Expert Panel stating that St. John’s Wort as used
in cosmetic emulsions is rather safe [91]. One reference
included in this short review tested a bath oil containing
St. John’s Wort on human skin and found it to be less
irritating than other tested bath oils and sodium lauryl
sulfate. It was well tolerated having the same effects
on the skin as the negative control, which was distilled
water [92].
Considering all these different aspects St. John’s Wort
may be helpful in the treatment of diseases like dermato-
phytosis, pyoderma/bacterial overgrowth, otitis externa
and infected wounds. Even if clinical research with St.
John’s Wort formulations in dogs is still missing it might
be considered beneficial for topical applications in the
treatment of canine skin diseases, maybe also as thera-
peutical shampoos.
Matricaria chamomilla - Chamomile
The traditional use of Chamomile for the treatment of
skin-related problems in livestock seems to be well-
established in Switzerland [17] and farmers using it
appear to be content with its effects [46]. This indicates
that there is a certain potential for Chamomile to be an
effective treatment in canine skin disorders as well.
For Chamomile 14 in vitro references evaluating the
antibacterial activity of its extracts were found and 11 of
them could show an effect. The in vitro references could
show inhibitory or even bactericidal effects of Chamomile
against a relatively broad range of bacteria including
E. coli, P. mirabilis, P. vulgaris, E. faecalis, A. baumanni,
Porphyromonas gingivalis, S. aureus, S. epidermidis and
other Staphylococci. The antimicrobial activity seemed
to be stronger against Gram-positive bacteria and
some references only provided evidence for an effect
against Gram-positive but not against Gram-negative
bacteria. Still, the inhibitory effect of Chamomile on
bacteria seems evident and in some references it did
present itself as being broad-ranged. One in vitro re-
ference demonstrated Chamomile crude extract to be
effective against methicillin-resistant S. epidermidis
and a synergistic interaction between oxacillin and
Chamomile was reported [93]. S. epidermidis is an im-
portant member of the canine skin microbiome [94]
and is not uncommonly isolated from canine skin and
ear infections [95, 96]. This shows that not only formu-
lations containing Chamomile alone should be considered
as new treatments but also formulations combining
Chamomile with certain antibiotics may enhance their
antimicrobial efficiency. Eight references described the an-
tifungal properties of Chamomile and five of them showed
it to be effective against M. canis, M. gypseum, T. men-
tagrophytes, T. rubrum, T. tonsurans, Aspergillus niger,
Aspergillus fumigatus, Candida albicans and each two
species of Trichophyton and Aspergillus genus
[97–101]. Three references did not show an antifungal
effect against C. albicans [68, 102, 103]. There were no
clinical or in vivo references investigating the antifungal
potential of Chamomile. The in vitro references
described above demonstrated that extracts of this
medicinal plant can be effective against dermatophytes
and certain yeasts.
Chamomile was the plant for which the most re-
ferences investigating anti-pruritic effects could be
included. One clinical reference did not show a clear
result concerning this effect but two clinical studies
on humans [37, 104] and one in vivo reference using
an AD mice model [35] did report Chamomile and its
constituent bisabolol to relieve itching. Even though
there were no publications found studying this effect
in dogs, it seems likely that Chamomile might have a
similar effect on dog skin as on human and mouse
skin. Formulations containing Chamomile could thus
have an additionally beneficial effect in the treatment
of secondary skin infections in atopic dogs, in wound
healing and other skin diseases associated with pruritus.
Five publications were included in this review studying
the wound-healing effect of Chamomile and sustaining
the traditional use of this plant for wound care [56].
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Chamomile was reported to be effective in the treatment
of experimental traumatic tongue ulcers, linear incisional
wounds, cutaneous burn wounds, and peristomal skin
lesions in human colostomy patients [104–108]. One re-
ference showed a collagen-enhancing effect of Chamomile
[105], and three references demonstrated the topical
anti-inflammatory effects of Chamomile [35, 104, 109]
which might also aid wound healing.
It is not surprising that besides the known and tradition-
ally used systemic anti-inflammatory effect of Chamomile
[15, 110], it also showed this effect when applied topically.
Due to its anti-inflammatory effects it could replace the
topical treatment with glucocorticoids not only in otitis
externa but also in the management of CAD [111] elimin-
ating the unwanted adverse effects resulting from the ste-
roids [112]. Moreover, two references reported an
analgesic effect of topically applied creams containing
Chamomile in human patients [104, 113]. Even though
there are reports of contact allergy to Chamomile in
human patients [114] it is not known if dogs may show
similar reactions. Considering the various beneficial effects
of this medicinal plant it seems reasonable to investigate
its use in dogs despite the unknown risk of provoking
adverse reactions.
Due to its broad spectrum of promising scientific results
Chamomile seems to be a therapeutic option in dogs
suffering from otitis externa, pyotraumatic dermatitis and
wounds. These patients might benefit not only from its
anti-microbial and anti-inflammatory activity, but also
from its analgesic effects.
One reference included in this review added Chamomile
hydrophobic extract to dishwashing liquids in order to
improve the safety of use. It was found that the extract
reduced the transepidermal water loss and improved the
skin hydration level in the human probands. Also, the
more Chamomile extract was added to the formulations,
the less irritant they were [115]. This effect should be con-
sidered in the development of dog shampoos for healthy
skin and presents another beneficial effect of therapeutic
shampoos containing Chamomile.
Salvia officinalis - sage
Sage leaf is used as a traditional relief of minor skin
inflammations and bacterial infections of the skin in
humans, and it has been known to have antibacterial
properties [116]. The references found in this review
showed that Sage is in fact effective against a range of
bacteria relevant in skin disease. A total of 21 in vitro
references investigated the antibacterial activity of Sage
and 20 of them found an antibacterial effect. Fifteen
references demonstrated that Sage inhibits the growth of
S. aureus, seven references showed it to be effective
against E. coli and six references found Sage to be effect-
ive against P. aeruginosa. Other bacteria against which
Sage showed an inhibitory effect included S. epidermidis
and other Staphylococcus spp., Acinetobacter baumannii,
Enterococcus faecalis, Enterococcus hirae, Propionibac-
terium acnes, Bacteroides vulgatus, Prevotella intermedia,
Porphyromonas gingivalis, P. vulgaris, Proteus mirabilis
and other Proteus spp. and several Streptococcus spp.
and Corynebacterium spp. In addition, methicillin-resist-
ant S. epidermidids was inhibited by Sage as well as
MRSA. These observations confirm that extracts of Sage
exert broad-spectrum antibacterial activity and are
effective even against resistant strains. There were no
clinical or in vivo references included in this review
which evaluated this effect of Sage on skin. Not only
Sage extracts alone, but also combinations of them with
antibiotics, seem to be very promising. A total of five
references reported synergistic activities between anti-
biotics and one preservative and extracts of Sage and four
of them could demonstrate such effects [93, 117–119].
Different extracts showed synergistic activity together with
tetracycline, amoxicillin, chloramphenicol, oxacillin and
the preservative propylparaben.
There were ten in vitro references investigating the
antifungal activity of Sage. Out of these ten studies,
seven reported it to be effective against a range of
dermatophytes, yeasts and fungi including T. menta-
grophytes [120–122], T. rubrum, T. verrucosum [120],
M. gypseum [120–122], M. canis [120, 122], and C.
albicans [120–126].
No reports on the potential adverse reactions to the top-
ical application of Sage on dog skin were found. A refer-
ence evaluating the effects of different constituents of
Sage on human gingival fibroblasts showed no toxicity.
Thus, Sage can be considered relatively safe in its use
on skin.
Given the promising results of the in vitro references
proving the antibacterial effect of Sage, it would be inter-
esting to further investigate the use of Sage in dogs with
bacterial skin diseases, ear or wound infections. Sage
was demonstrated to have anti-bacterial as well as
anti-inflammatory properties. Combining these two
properties, Sage seems promising for the treatment of
primary or secondary skin infections and in the treat-
ment of otitis externa. Also, the treatment of infected
wounds could benefit from the anti-inflammatory com-
ponent additional to the antibacterial effect. The refer-
ences proving the antifungal effect of Sage showed that
Sage could be effective in the treatment of dermatophyt-
osis. Growth inhibition of C. albicans by Sage indicates a
possible additional activity of Sage against M. pachyder-
matis, thus, indicating Sage’s possible properties in the
treatment of skin and ear infections involving this yeast
species [127]. This is especially of interest as treatment
failure and rapid recurrences of these infections are
common [127].
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Conclusions
All plants evaluated in this review possess a certain anti-
bacterial potential and might be useful as a first-line top-
ical treatment for primary and secondary skin infections,
in surgical wound care, in wound infections and otitis
externa. As antibiotic-resistant bacteria were shown to
be susceptible to extracts of these plants, they present a
possible new option for the treatment of dogs infected
with germs resistant to antimicrobials. The same holds
true for the antifungal effects of these four plants
described. Hence, they might present an additional option
for the treatment of dermatophytosis as well as skin and
ear infections involving M. pachydermatis and even der-
matophytes. Marigold, St. John’s Wort and Chamomile
were reported to have wound-healing properties and thus,
they represent promising candidates in line to fill the
therapeutic gap in canine wound-healing agents. St. John’s
Wort and Chamomile are the most promising species
based on the findings of this review regarding anti-inflam-
matory effects. Thus, these plants may be used in a wide
range of canine skin diseases with an inflammatory com-
ponent. For the treatment of otitis externa and other
painful skin conditions the topical treatment with St.
John’s Wort and Chamomile should be considered.
Chamomile and St. John’s Wort have been shown to
have beneficial effects even on healthy skin. These two
plants could thus be an interesting additive for skin care
products like dog shampoos or sprays. Ultimately, each
of the plants investigated in this review combines several
beneficial effects for the treatment of skin disease which
makes them especially interesting due to their specific
multicomponent composition. Some studies reported
safety concerns in humans for these four medicinal
plants. It is unknown if these apply to dogs too. How-
ever, as there are also several studies proving the use of
these plants to be safe in humans, and as the beneficial
effects of these plants are undeniable, these medicinal
plants should be taken into account as therapeutic
options for skin disorders associated with microbial
infections/dysbalance and wound management in dogs,
at least in future clinical research.
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